Inotiv (NOTVQ) Liabilities and Shareholders Equity (2010 - 2026)
Inotiv's (NOTVQ) quarterly Liabilities and Shareholders Equity came in at $702.4 million in Q1 2026, down 8.3% YoY from $766.0 million in Q1 2025, and down 4.35% on a QoQ basis from $734.3 million in Q4 2025.
Inotiv (NOTVQ) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Inotiv (NOTVQ) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $702.4 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 8.3% year-over-year to $702.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 4.11% YoY) and the FY2025 annual result came in at $771.1 million, down 1.31% from the prior year.
- Liabilities and Shareholders Equity slipped to $702.4 million in Q1 2026, from $734.3 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.2 billion in Q2 2022 to a low of $702.4 million in Q1 2026.
- A 5-year average of $849.1 million and a median of $815.4 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 1664.6% — and 2023, when it retreated 26.8%.
- Tracing NOTVQ's Liabilities and Shareholders Equity over 5 years: stood at $871.1 million in 2022, then slipped by 4.08% to $835.5 million in 2023, then retreated by 7.49% to $772.9 million in 2024, then declined by 4.99% to $734.3 million in 2025, then declined by 4.35% to $702.4 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $702.4 million (Q1 2026), $734.3 million (Q4 2025), and $771.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 3.44 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 16.94 Bn |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | 702.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 702.42 Mn |
| Dec 31, 2025 | 734.34 Mn |
| Sep 30, 2025 | 771.11 Mn |
| Jun 30, 2025 | 759.74 Mn |
| Mar 31, 2025 | 765.97 Mn |
| Dec 31, 2024 | 772.91 Mn |
| Sep 30, 2024 | 781.36 Mn |
| Jun 30, 2024 | 774.59 Mn |
| Mar 31, 2024 | 815.38 Mn |
| Dec 31, 2023 | 835.51 Mn |
| Sep 30, 2023 | 856.53 Mn |
| Jun 30, 2023 | 854.83 Mn |
| Mar 31, 2023 | 868.67 Mn |
| Dec 31, 2022 | 871.06 Mn |
| Sep 30, 2022 | 962.90 Mn |
| Jun 30, 2022 | 1.17 Bn |
| Mar 31, 2022 | 1.14 Bn |
| Dec 31, 2021 | 1.00 Bn |
| Sep 30, 2021 | 321.86 Mn |
| Jun 30, 2021 | 176.74 Mn |